Expression of inducible nitric oxide synthase and formation of peroxynitrite in posttransplant obliterative bronchiolitis.
BACKGROUND
Obliterative bronchiolitis is characterized histologically by inflammation, epithelial cell damage and loss, fibrosis, and eventual obliteration of airways. Production of high levels of the potential cytotoxin nitric oxide by inducible nitric oxide synthase has been implicated in several inflammatory diseases. The damaging effects of nitric oxide are mediated by peroxynitrite, are formed from nitric oxide and superoxide, and can be demonstrated by the detection of nitrotyrosine. Our previous finding of high inducible nitric oxide synthase expression in inflamed airway epithelium led us to hypothesize that release of nitric oxide in obliterative bronchiolitis mediates the characteristic epithelial damage.


METHODS
Immunocytochemistry was carried out to seek expression of inducible nitric oxide synthase and nitrotyrosine in transplant samples from patients with obliterative bronchiolitis (n=10) and, as controls, unused donor lungs (n=5).


RESULTS
Inducible nitric oxide synthase was strongly expressed in the damaged airway epithelium in obliterative bronchiolitis and in inflammatory cells, where its distribution was matched by that of nitrotyrosine. Normal controls showed little or no immunoreactivity for any of the antigens studied.


CONCLUSIONS
Our findings suggest that nitric oxide may play a role in the pathogenesis of obliterative bronchiolitis and indicate that further work is essential to fully understand the processes and mechanisms involved.
Mason
N A
NA
Department of Histochemistry, Royal Postgraduate Medical School, London, United Kingdom.
Springall
D R
DR
Pomerance
A
A
Evans
T J
TJ
Yacoub
M H
MH
Polak
J M
JM
D001989:Bronchiolitis Obliterans / Q000209:etiology / Q000378:metabolism*; D016041:Heart-Lung Transplantation; D006801:Humans; D008168:Lung / Q000378:metabolism; D016040:Lung Transplantation; D009566:Nitrates / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052247:Nitric Oxide Synthase Type II; D016877:Oxidants / Q000378:metabolism*; D011183:Postoperative Complications / Q000378:metabolism*
D009566:Nitrates; D016877:Oxidants; C039642:peroxynitric acid; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II